Prafulkumar Tulshibhai Chovatia,Martin Clive Hutchings,Boris Kroeplien,James Thomas Reuberson
申请号：
US15580054
公开号：
US20180222868A1
申请日:
2016.06.07
申请国别(地区):
US
年份:
2018
代理人:
摘要：
A series of substituted indazole derivatives, being potent modulators of human TNFa activity, are accordingly of benefit in the treatment and/or prevention of various human ailments, including autoimmune and inflammatory disorders； neurological and neurodegenerative disorders； pain and nociceptive disorders； cardiovascular disorders； metabolic disorders； ocular disorders； and oncological disorders.
